Filing Flows › Ionis Pharmaceuticals (IONS) › Research and Development Revenue revenue
Ionis Pharmaceuticals (IONS) Research and Development Revenue revenue by quarter
Ionis Pharmaceuticals' Research and Development Revenue revenue was $150M in Q2 2026 (second quarter 2026), +8% from Q1 2026. Over the last 5 quarters it ranged from $55.4M (Q1 2025) to $350M (Q2 2025).
| Quarter | Research and Development Revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $150M | +8% | -57% |
| Q1 2026 | $138M | -61% | +149% |
| Q2 2025 | $350M | +532% | — |
| Q1 2025 | $55.4M | -61% | — |
| Q4 2024 | $141M | — | — |
Q2 2026 at a glance
Ionis Pharmaceuticals, Q2 2026: revenue $268M (-41% year over year), operating margin -38.2%, net loss $115M, operating cash flow $566M. The chart follows the revenue to costs, profit and cash.
Questions
What is Ionis Pharmaceuticals' Research and Development Revenue revenue?
Ionis Pharmaceuticals' Research and Development Revenue revenue was $150M in Q2 2026 (second quarter 2026), +8% from Q1 2026.
How has Ionis Pharmaceuticals' Research and Development Revenue revenue changed?
Over the last 5 quarters it ranged from $55.4M (Q1 2025) to $350M (Q2 2025).